APOA1 and metabolic dysfunction-associated steatotic liver disease: The mechanism underlying UAR’s good diagnostic ability for MASLD may be linked to the promotion of insulin resistance by UA, as well as the anti-insulin resistance properties of APOA1, indicating that elevated UAR could reflect an imbalance between pro-insulin resistance and anti-insulin resistance metabolic profiles.